Over half of women in the US who are breastfeeding their infants take prescription drugs. You are being asked to participate in this study because you are breastfeeding your infant and are currently taking, as part of your medical care, at least one of the drugs we are studying. We are interested in studying drugs commonly prescribed to women who are breastfeeding so we can learn more about the amount of drug that is transferred to breastmilk and estimate how much of drug that is consumed by breastfed infants.
Conditions
- Lactating Women on Select DOI
- Breastfed Infants of Mothers on Select DOI
Intervention
- Tranexamic acid (TXA)
- labetalol
- metformin
- nifedipine
- clindamycin
- oxycodone
- azithromycin
- escitalopram
- sertraline
- ondansetron
- Ciprofloxacin
- Doxycycline
- Levofloxacin
- Methylphenidate
- Sumatriptan
- Citalopram
- Cyclobenzaprine
- Furosemide
- Gabapentin
- Hydrochlorothiazide
- Hydroxyurea
- Rosuvastatin
- Topiramate
- Trazodone
- Valganciclovir
- Venlafaxine
- Verapamil
- Remdesivir
- Anakinra
- Tocilizumab
- Fluvoxamine
- Amoxicillin
- Bupropion
- Duloxetine
- Hydrocodone
- Levetiracetam
- Paroxetine
- Buprenorphine
Principal Investigator
- Ngo, Larry
Sponsor
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 05/01/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.
Request Information
Complete the form below to contact the study team and receive more information about this trial.